| Empagliflozin |
| (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol |
| (CAS 864070-44-0) |
 |
| Description： |
Empagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >300-fold selectivity over SGLT-1, 4, 5 and 6.
IC50 value: 3.1 nM
Target: SGLT-2
Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in the proximal tubules of nephronic components in the kidneys. SGLT-2 accounts for about 90 percent of glucose reabsorption into the blood. Blocking SGLT-2 causes blood glucose to be eliminated through the urine via the urethra. The Empagliflozin phase III clinical trial program will include about 14,500 patients. The program consists of twelve ongoing international phase III clinical trials, including a large cardiovascular outcomes trial.
|
| Product No. |
KT20204 |
| Product Name |
Empagliflozin |
| Synonyms |
BI-10773; BI 10773; BI10773 |
| Formal Name |
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol |
| CAS Number |
864070-44-0 |
| Molecular Formula |
C23H27ClO7 |
| Formula Weight |
450.91 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
SGLT2 inhibitor
Canagliflozin
Canagliflozin hemihydrate
Dapagliflozin
Dapagliflozin(2S)-1,2-propanediol,hydrate
Ipragliflozin
LX-4211
PF-04971729
Phloretin
Phlorizin
|
|
